author-photo

E. Ramsay Camp

University of Texas MD Anderson Cancer Center

13

Papers

1247

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Abstract 3012: The CaSm oncogene promotes proliferation, invasion, and chemoresistance of pancreatic cancer cells.

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
ASSOCIATION FOR ACADEMIC SURGERY Slug Expression Enhances Tumor Formation in a Noninvasive Rectal Cancer Model

2011
Show All
- Source
- Cite
- Save
Citations (1)
Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells

2008 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (33)
Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.

2007 Cancer
Show All
- Source
- Cite
- Save
Citations (83)
The Development and Characterization of a Human Midgut Carcinoid Cell Line

2007 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (46)
Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells

2006 Cancer Research
Show All
- Source
- Cite
- Save
Citations (231)
Roles of Nitric Oxide Synthase Inhibition and Vascular Endothelial Growth Factor Receptor-2 Inhibition on Vascular Morphology and Function in an In vivo Model of Pancreatic Cancer

2006 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (32)
Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines

2006 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (417)
The role of nitric oxide in mediating tumour blood flow

2006 Expert Opinion on Therapeutic Targets
Show All
- Source
- Cite
- Save
Citations (9)
Molecular Mechanisms of Resistance to Therapies Targeting the Epidermal Growth Factor Receptor

2005 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (194)